Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
IMVARIA Announces Strategic Investments from Leading Healthcare Companies
Company…
What You Should Know
– Ultrahuman, the global leader in wearable health technology, has partnered with Click Therapeutics to develop the Migraine PowerPlug. This first-of-its-kind tool integrates the proprietary technology behind Click’s CT-132—the first and…
Continue Reading
What You Should Know:
– PathAI has secured a historic regulatory milestone with the FDA qualification of its AIM-MASH AI Assist tool, making it the first AI-powered pathology biomarker to receive such status under the…
Continue Reading
Henry O’Connell, CEO and co-founder of Canary Speech
Vocal biomarker data has come a long way in a short amount of time. No longer relegated to the pages of science fiction, the power of the…
Continue Reading
Background: Keystroke dynamics on smartphones have emerged as a promising form of passive digital biomarker. While previous studies have explored their utility in several diseases and disorders, relatively few have examined how these dynamics…
Continue Reading
What You Should Know:
– Function has created a new category in preventive health—one that shifts how people think about longevity, early detection, and everyday decision-making. The company’s mission is simple but ambitious: empower people to…
Continue Reading
The complexity and variability of high-resolution pathological images present significant challenges in computational pathology. While AI-driven pathology foundation models have advanced the field, they require large-scale datasets, substantial storage, and significant computational resources, as…
Continue Reading
What You Should Know:
– Function has created a new category in preventive health—one that shifts how people think about longevity, early detection, and everyday decision-making. The company’s mission is simple but ambitious: empower people to…
Continue Reading
What You Should Know:
– Lunit, a provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader in innovative and comprehensive laboratory services, today announced a strategic collaborative initiative. The partnership…
Continue Reading
The use of large language models (LLMs) in clinical diagnostics and intervention planning is expanding, yet their utility for personalized recommendations for longevity interventions remains opaque. We extended the BioChatter framework to benchmark LLMs’…
Continue Reading
